Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADONIS: NRT Dose Adjustment in High-Risk Smokers
NCT00235313Phase 4Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Oct 2005
- Primary completion
- Nov 2007
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of nicotine patch in nicotine dependence (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Sustained Smoking Abstinence at 3 months. Started Oct 2005; status: completed.
02
Drugs
nicotine patch
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT00235313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00235313.